Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Alexandria Macmadu, Kelly K. Gurka, Herbert I. Linn, Gordon S. Smith & Judith Feinberg. (2023) Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural Appalachia. Substance Use & Misuse 58:2, pages 163-170.
Read now
Read now
Sean T. Allen, Allison O’Rourke, Jessica. A. Johnson, Chelsi Cheatom, Ying Zhang, Brandon Delise, Kellie Watkins, Kathleen Reich, Rick Reich & Cassius Lockett. (2022) Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Annals of Medicine 54:1, pages 2680-2688.
Read now
Read now
Michael D. Serrano & Timothy B. Conley. (2021) The role of social work and peer support workers in addressing the opioid crisis. Social Work in Mental Health 19:6, pages 517-525.
Read now
Read now
Hong K. Kim, Nicholas J. Connors & Maryann E. Mazer-Amirshahi. (2019) The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Expert Opinion on Drug Safety 18:6, pages 465-475.
Read now
Read now
Carley Marshall, Myra Piat & Michel Perreault. (2018) Exploring the psychological benefits and challenges experienced by peer-helpers participating in take-home naloxone programmes: A rapid review. Drugs: Education, Prevention and Policy 25:3, pages 280-291.
Read now
Read now
Christa R Lewis, Hoa T Vo & Marc Fishman. (2017) Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review. Substance Abuse and Rehabilitation 8, pages 79-95.
Read now
Read now
Michael W. Willman, David B. Liss, Evan S. Schwarz & Michael E. Mullins. (2017) Do heroin overdose patients require observation after receiving naloxone?. Clinical Toxicology 55:2, pages 81-87.
Read now
Read now
Elizabeth M. Oliva, Andrea Nevedal, Eleanor T. Lewis, Matthew D. McCaa, Michael F. Cochran, P. Eric Konicki, Corey S. Davis & Christine Wilder. (2016) Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Substance Abuse 37:1, pages 118-126.
Read now
Read now
Lisham Ashrafioun, Stephanie Gamble, Michele Herrmann & Gloria Baciewicz. (2016) Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods. Substance Abuse 37:1, pages 76-81.
Read now
Read now
Shane R. Mueller, Alexander Y. Walley, Susan L. Calcaterra, Jason M. Glanz & Ingrid A. Binswanger. (2015) A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Substance Abuse 36:2, pages 240-253.
Read now
Read now
Suzanne Doyon, Steven E. Aks & Scott Schaeffer. (2014) Expanding access to naloxone in the United States. Clinical Toxicology 52:10, pages 989-992.
Read now
Read now
Phillip O. Coffin & Sean D. Sullivan. (2013) Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. Journal of Medical Economics 16:8, pages 1051-1060.
Read now
Read now
Nickolas D. Zaller, Michael A. Yokell, Traci Craig Green, Julia Gaggin & Patricia Case. (2013) The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island. Substance Use & Misuse 48:8, pages 590-599.
Read now
Read now
Linda Webster, Anna Eisenberg, AmyS. B. Bohnert, Felicia Kleinberg & MarkA. Ilgen. (2012) Qualitative Evaluation of Suicide and Overdose Risk Assessment Procedures Among Veterans in Substance Use Disorder Treatment Clinics. Archives of Suicide Research 16:3, pages 250-262.
Read now
Read now
Articles from other publishers (87)
Eric J. Lavonas, Peter D. Akpunonu, Ann M. Arens, Kavita M. Babu, Dazhe Cao, Robert S. Hoffman, Christopher O. Hoyte, Maryann E. Mazer-Amirshahi, Andrew Stolbach, Maude St-Onge, Trevonne M. Thompson, George Sam Wang, Amber V. Hoover & Ian R. Drennan. (2023) 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation.
Crossref
Crossref
Melody Rachel Konadu Frempong. (2023) “It Saved My Life Three Times, I Could Have Died”: Exploring the Perceptions of Peer-Administered Naloxone Program in Spain. Global Social Welfare.
Crossref
Crossref
Michelle Olding, Jade Boyd, Thomas Kerr, Al Fowler & Ryan McNeil. (2023) (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada. International Journal of Drug Policy 111, pages 103929.
Crossref
Crossref
Nicholas Alexander Bascou, Benjamin Haslund-Gourley, Katrina Amber-Monta, Kyle Samson, Nathaniel Goss, Dakota Meredith, Andrew Friedman, Andrew Needleman, Vishnu K. Kumar & Bradford D. Fischer. (2022) Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population. Harm Reduction Journal 19:1.
Crossref
Crossref
Michael Wilson, Amanda Brumwell, M. J. Stowe, Shaun Shelly & Andrew Scheibe. (2022) Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs. Harm Reduction Journal 19:1.
Crossref
Crossref
Øystein Bruun Ericson, Desiree Eide, Philipp Lobmaier & Thomas Clausen. (2022) Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program. Drug and Alcohol Dependence 240, pages 109645.
Crossref
Crossref
Hawraa Sameer Sajwani & Anna V Williams. (2022) A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs. Harm Reduction Journal 19:1.
Crossref
Crossref
Jermaine D. Jones, Aimee N. Campbell, Laura Brandt, Verena E. Metz, Suky Martinez, Melanie Wall, Thomas Corbeil, Howard Andrews, Felipe Castillo, Joanne Neale, John Strang, Stephen Ross & Sandra D. Comer. (2022) A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. Drug and Alcohol Dependence 237, pages 109505.
Crossref
Crossref
Phillip O. Coffin, Sigal Maya & James G. Kahn. (2022) Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug and Alcohol Dependence 236, pages 109478.
Crossref
Crossref
Thomas Griner & Sheryl Strasser. (2021) A qualitative examination of responses from a survey of pharmacy staff in Georgia regarding access to Narcan®. Health Education Research 36:4, pages 467-477.
Crossref
Crossref
Fiona Mercer, Joanna Astrid Miler, Bernie Pauly, Hannah Carver, Kristina Hnízdilová, Rebecca Foster & Tessa Parkes. (2021) Peer Support and Overdose Prevention Responses: A Systematic ‘State-of-the-Art’ Review. International Journal of Environmental Research and Public Health 18:22, pages 12073.
Crossref
Crossref
Laura Brandt, Takuya Yanagida, Aimee N. C. Campbell, Jermaine D. Jones, Marie-Therese Schultes, Suky Martinez & Sandra D. Comer. (2021) Multi-informant Implementation and Intervention Outcomes of Opioid Overdose Education and Naloxone Distribution in New York City. Global Implementation Research and Applications 1:3, pages 209-222.
Crossref
Crossref
Elizabeth A. Samuels, Anna Wentz, Meghan McCormick, James V. McDonald, Brandon D.L. Marshall, Catherine Friedman, Jennifer Koziol & Nicole E. Alexander-Scott. (2021) Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment. Annals of Emergency Medicine 78:1, pages 68-79.
Crossref
Crossref
Tony Antoniou, Diana Martins, Tonya Campbell, Mina Tadrous, Charlotte Munro, Pamela Leece, Muhammad Mamdani, David N. Juurlink & Tara Gomes. (2021) Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis. Addiction 116:6, pages 1514-1520.
Crossref
Crossref
Elizabeth A. Samuels, Edouard CoupetJrJr & Gail D’Onofrio. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
57
75
.
Elizabeth A. Samuels, Ziming Xuan & Edward Bernstein. 2021. Social Emergency Medicine. Social Emergency Medicine
157
184
.
Taylor J. Holland, Jonathan Penm, Jacinta Johnson, Maria Sarantou & Betty B. Chaar. (2020) Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone. Pharmacy 8:4, pages 232.
Crossref
Crossref
Bridget L. Hanson, Rebecca R. Porter, Amanda L. Zöld & Heather Terhorst-Miller. (2020) Preventing opioid overdose with peer-administered naloxone: findings from a rural state. Harm Reduction Journal 17:1.
Crossref
Crossref
Katja Troberg, Pernilla Isendahl, Marianne Alanko Blomé, Disa Dahlman & Anders Håkansson. (2020) Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden. BMC Psychiatry 20:1.
Crossref
Crossref
Adam Cheng, David J. Magid, Marc Auerbach, Farhan Bhanji, Blair L. Bigham, Audrey L. Blewer, Katie N. Dainty, Emily Diederich, Yiqun Lin, Marion Leary, Melissa Mahgoub, Mary E. Mancini, Kenneth Navarro & Aaron Donoghue. (2020) Part 6: Resuscitation Education Science: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142:16_suppl_2.
Crossref
Crossref
Keith Chichester, Michelle L. Sisson, Samantha P. Schiavon, Mickeah J. Hugley, Peter S. Hendricks, Richard C. Shelton & Karen L. Cropsey. (2020) Naloxone Training From Nonmedical Personnel: Benefits Before, During, and After Overdose Events. Journal of Addiction Medicine 14:5, pages e220-e225.
Crossref
Crossref
Marcelo H. Fernández-Viña, Nadya E. Prood, Adam Herpolsheimer, Joshua Waimberg & Scott Burris. (2020) State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019. Public Health Reports 135:1_suppl, pages 128S-137S.
Crossref
Crossref
Quintin E. Wright, Suzanne Higginbotham, Elizabeth Bunk & Jordan R. Covvey. (2020) The impact of a pharmacist-led naloxone education and community distribution project on local use of naloxone. Journal of the American Pharmacists Association 60:3, pages S56-S60.
Crossref
Crossref
Joanna G. Katzman, Mikiko Y. Takeda, Nina Greenberg, Monica Moya Balasch, Amal Alchbli, William G. Katzman, Julie G. Salvador & Snehal R. Bhatt. (2020) Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program. JAMA Network Open 3:2, pages e200117.
Crossref
Crossref
Claire Keen, Stuart A. Kinner, Rohan Borschmann & Jesse T. Young. (2020) Comparing the predictive capability of self-report and medically-verified non-fatal overdose in adults released from prison: A prospective data linkage study. Drug and Alcohol Dependence 206, pages 107742.
Crossref
Crossref
Rebecca L Haffajee & Cecelia A French. (2019) Provider perceptions of system-level opioid prescribing and addiction treatment policies. Current Opinion in Psychology 30, pages 65-73.
Crossref
Crossref
Sean T. Allen, Rebecca Hamilton White, Allison O’Rourke, Suzanne M. Grieb, Michael E. Kilkenny & Susan G. Sherman. (2019) Take-home naloxone possession among people who inject drugs in rural West Virginia. Drug and Alcohol Dependence 204, pages 107581.
Crossref
Crossref
Rebecca B. Naumann, Christine Piette Durrance, Shabbar I. Ranapurwala, Anna E. Austin, Scott Proescholdbell, Robert Childs, Stephen W. Marshall, Susan Kansagra & Meghan E. Shanahan. (2019) Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug and Alcohol Dependence 204, pages 107536.
Crossref
Crossref
Jamie K. Lim, Leah S. Forman, Sarah Ruiz, Ziming Xuan, Barry P. Callis, Kevin Cranston & Alexander Y. Walley. (2019) Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts. Drug and Alcohol Dependence 204, pages 107531.
Crossref
Crossref
Danielle N. Atkins, Christine Piette Durrance & Yuna Kim. (2019) Good Samaritan harm reduction policy and drug overdose deaths. Health Services Research 54:2, pages 407-416.
Crossref
Crossref
Alison Sutter, Matt Curtis & Taeko Frost. (2019) Public drug use in eight U.S. cities: Health risks and other factors associated with place of drug use. International Journal of Drug Policy 64, pages 62-69.
Crossref
Crossref
Elizabeth A. Samuels, Steven L. Bernstein, Brandon D.L. Marshall, Maxwell Krieger, Janette Baird & Michael J. Mello. (2018) Peer navigation and take-home naloxone for opioid overdose emergency department patients: Preliminary patient outcomes. Journal of Substance Abuse Treatment 94, pages 29-34.
Crossref
Crossref
Elizabeth A. Samuels, Janette Baird, Eunice S. Yang & Michael J. Mello. (2018) Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program. Academic Emergency Medicine.
Crossref
Crossref
Stephanie M. Mathis, Nicholas Hagemeier, Angela Hagaman, John Dreyzehner & Robert P. Pack. (2018) A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States. Current HIV/AIDS Reports 15:5, pages 359-370.
Crossref
Crossref
Louisa Gilbert, Timothy Hunt, Sholpan Primbetova, Assel Terlikbayeva, Mingway Chang, Elwin Wu, Tara McCrimmon & Nabila El-Bassel. (2018) Reducing opioid overdose in Kazakhstan: A randomized controlled trial of a couple-based integrated HIV/HCV and overdose prevention intervention “Renaissance”. International Journal of Drug Policy 54, pages 105-113.
Crossref
Crossref
Rachael Rzasa Lynn & JL Galinkin. (2017) Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic Advances in Drug Safety 9:1, pages 63-88.
Crossref
Crossref
Vincent N. Van NessIIIIII. 2018. Translating National Policy to Improve Environmental Conditions Impacting Public Health Through Community Planning. Translating National Policy to Improve Environmental Conditions Impacting Public Health Through Community Planning
285
303
.
Phillip Oliver Coffin, Glenn-Milo Santos, Tim Matheson, Emily Behar, Chris Rowe, Talia Rubin, Janelle Silvis & Eric Vittinghoff. (2017) Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLOS ONE 12:10, pages e0183354.
Crossref
Crossref
Rebecca McDonald, Nancy D. Campbell & John Strang. (2017) Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids—Conception and maturation. Drug and Alcohol Dependence 178, pages 176-187.
Crossref
Crossref
Michele Calvo, Jessica MacFarlane, Heather Zaccaro, Matthew Curtis, María Cabán, Jamie Favaro, Marian R. Passannante & Taeko Frost. (2017) Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks. Drug and Alcohol Dependence 178, pages 106-114.
Crossref
Crossref
Jenny Edwards, Duane Bates, Brett Edwards, Sunita Ghosh & Mark Yarema. (2017) PHArmacists’ perspective oN the Take hOme naloxone prograM (The PHANTOM Study). Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 150:4, pages 259-268.
Crossref
Crossref
Rachel Faulkner-Gurstein. (2017) The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science & Medicine 180, pages 20-27.
Crossref
Crossref
Desiree Madah-Amiri, Thomas Clausen & Philipp Lobmaier. (2017) Rapid widespread distribution of intranasal naloxone for overdose prevention. Drug and Alcohol Dependence 173, pages 17-23.
Crossref
Crossref
Shalini Wickramatilake, Julia Zur, Norah Mulvaney-Day, Melinda Campopiano von Klimo, Elizabeth Selmi & Henrick Harwood. (2017) How States Are Tackling the Opioid Crisis. Public Health Reports 132:2, pages 171-179.
Crossref
Crossref
Carley Marshall, Michel Perreault, Léonie Archambault & Diana Milton. (2017) Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study. International Journal of Drug Policy 41, pages 19-28.
Crossref
Crossref
Leo Kobayashi, Traci C. Green, Sarah E. Bowman, Madeline C. Ray, Michelle S. McKenzie & Josiah D. Rich. (2017) Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort. Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare 12:1, pages 22-27.
Crossref
Crossref
Tristan I. Evans, Scott E. Hadland, Melissa A. Clark, Traci C. Green & Brandon D. L. Marshall. (2016) Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduction Journal 13:1.
Crossref
Crossref
Andrew Deonarine, Ashraf Amlani, Graham Ambrose & Jane A. Buxton. (2016) Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia. Harm Reduction Journal 13:1.
Crossref
Crossref
Arun Sondhi, George Ryan & Ed Day. (2016) Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England. Harm Reduction Journal 13:1.
Crossref
Crossref
Harshal Kirane, Michael Ketteringham, Sewit Bereket, Richie Dima, Ann Basta, Sonia Mendoza & Helena Hansen. (2016) Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention. Journal of Substance Abuse Treatment 69, pages 44-49.
Crossref
Crossref
Jamie K. Lim, Jeffrey P. Bratberg, Corey S. Davis, Traci C. Green & Alexander Y. Walley. (2016) Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. Journal of Addiction Medicine 10:5, pages 300-308.
Crossref
Crossref
Rebecca McDonald & John Strang. (2016) Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 111:7, pages 1177-1187.
Crossref
Crossref
Suzanne Doyon, Carleigh Benton, Bruce A. Anderson, Michael Baier, Erin Haas, Lisa Hadley, Jennifer Maehr, Kathleen Rebbert-Franklin, Yngvild Olsen & Christopher Welsh. (2016) Incorporation of poison center services in a state-wide overdose education and naloxone distribution program. The American Journal on Addictions 25:4, pages 301-306.
Crossref
Crossref
Ernest Drucker, Kenneth Anderson, Robert Haemmig, Robert Heimer, Dan Small, Alex Walley, Evan Wood & Ingrid van Beek. (2016) Treating Addictions: Harm Reduction in Clinical Care and Prevention. Journal of Bioethical Inquiry 13:2, pages 239-249.
Crossref
Crossref
Brandon D.L. Marshall, Traci C. Green, Jesse L. Yedinak & Scott E. Hadland. (2016) Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. International Journal of Drug Policy 31, pages 25-31.
Crossref
Crossref
Elizabeth A. Samuels, Kristin Dwyer, Michael J. Mello, Janette Baird, Adam R. Kellogg & Edward Bernstein. (2016) Emergency Department-based Opioid Harm Reduction: Moving Physicians From Willing to Doing. Academic Emergency Medicine 23:4, pages 455-465.
Crossref
Crossref
Corey S. Davis & Derek Carr. (2015) Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug and Alcohol Dependence 157, pages 112-120.
Crossref
Crossref
Corey S. DavisDerek CarrJessica K. SouthwellLeo Beletsky. (2015) Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration. American Journal of Public Health 105:8, pages 1530-1537.
Crossref
Crossref
Marcus A. Bachhuber, Emma E. McGinty, Alene Kennedy-Hendricks, Jeff Niederdeppe & Colleen L. Barry. (2015) Messaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey Experiment. PLOS ONE 10:7, pages e0130050.
Crossref
Crossref
Simon Lenton, Paul Dietze, Anna Olsen, Nicole Wiggins, David McDonald & Carrie Fowlie. (2015) Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug and Alcohol Review 34:4, pages 404-411.
Crossref
Crossref
Z. Marshall, M.K. Dechman, A. Minichiello, L. Alcock & G.E. Harris. (2015) Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug and Alcohol Dependence 151, pages 1-14.
Crossref
Crossref
Maya Doe-Simkins, Emily Quinn, Ziming Xuan, Amy Sorensen-Alawad, Holly Hackman, Al Ozonoff & Alexander Y Walley. (2014) Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health 14:1.
Crossref
Crossref
Tamara M. Haegerich, Leonard J. Paulozzi, Brian J. Manns & Christopher M. Jones. (2014) What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug and Alcohol Dependence 145, pages 34-47.
Crossref
Crossref
Suzanne Doyon, Steven E. Aks & Scott Schaeffer. (2014) Expanding Access to Naloxone in the United States. Journal of Medical Toxicology 10:4, pages 431-434.
Crossref
Crossref
Kari Lancaster & Alison Ritter. (2014) Making change happen: A case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction. International Journal of Drug Policy 25:5, pages 985-991.
Crossref
Crossref
D. Tzemis, D. Al-Qutub, A. Amlani, S. Kesselring & J. A. Buxton. (2014) A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open 2:3, pages E153-E161.
Crossref
Crossref
Angela K. Clark, Christine M. Wilder & Erin L. Winstanley. (2014) A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs. Journal of Addiction Medicine 8:3, pages 153-163.
Crossref
Crossref
Robert J. Tait & Simon Lenton. (2014)
Commentary on Williams
et al
. (2014): Family matters-new resources for managing opioid overdose with take-home naloxone
. Addiction 109:2, pages 260-261.
Crossref
Crossref
Anna V. Williams, John Marsden & John Strang. (2014) Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction 109:2, pages 250-259.
Crossref
Crossref
Timothy J. Inocencio, Norman V. Carroll, Edward J. Read & David A. Holdford. (2013) The Economic Burden of Opioid-Related Poisoning in the United States. Pain Medicine 14:10, pages 1534-1547.
Crossref
Crossref
Anna V. Williams, John Strang & John Marsden. (2013) Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug and Alcohol Dependence 132:1-2, pages 383-386.
Crossref
Crossref
Thomas Kerr, Will Small, Elaine Hyshka, Lisa Maher & Kate Shannon. (2013) ‘It's more about the heroin’: injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction 108:7, pages 1270-1276.
Crossref
Crossref
Pamela N. Leece, Shaun Hopkins, Chantel Marshall, Aaron Orkin, Margaret A. Gassanov & Rita M. Shahin. (2013) Development and Implementation of an Opioid Overdose Prevention and Response Program in Toronto, Ontario. Canadian Journal of Public Health 104:3, pages e200-e204.
Crossref
Crossref
Alexander Y. Walley, Maya Doe-Simkins, Emily Quinn, Courtney Pierce, Ziming Xuan & Al Ozonoff. (2013) Opioid overdose prevention with intranasal naloxone among people who take methadone. Journal of Substance Abuse Treatment 44:2, pages 241-247.
Crossref
Crossref
Stephen E. Lankenau, Karla D. Wagner, Karol Silva, Aleksandar Kecojevic, Ellen Iverson, Miles McNeely & Alex H. Kral. (2012) Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses. Journal of Community Health 38:1, pages 133-141.
Crossref
Crossref
Jennifer McNeely, Joshua D Lee & Ellie Grossman. 2013. Addressing Unhealthy Alcohol Use in Primary Care. Addressing Unhealthy Alcohol Use in Primary Care
129
145
.
Amy S.B. Bohnert, Melissa Tracy & Sandro Galea. (2012) Characteristics of drug users who witness many overdoses: Implications for overdose prevention. Drug and Alcohol Dependence 120:1-3, pages 168-173.
Crossref
Crossref
Alex S. Bennett, Alice Bell, Laura Tomedi, Eric G. Hulsey & Alex H. Kral. (2011) Characteristics of an Overdose Prevention, Response, and Naloxone Distribution Program in Pittsburgh and Allegheny County, Pennsylvania. Journal of Urban Health 88:6, pages 1020-1030.
Crossref
Crossref
Su Albert, Fred W. BrasonIIII, Catherine K. Sanford, Nabarun Dasgupta, Jim Graham & Beth Lovette. (2011) Project Lazarus: Community-Based Overdose Prevention in Rural North Carolina. Pain Medicine 12:suppl 2, pages S77-S85.
Crossref
Crossref
Soraya Mayet, Victoria Manning, Anna Williams, Jessica Loaring & John Strang. (2011) Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: Effective, but dissemination is challenging. International Journal of Drug Policy 22:1, pages 9-15.
Crossref
Crossref
Montserrat Neira-León, Gregorio Barrio, María J. Bravo, M. Teresa Brugal, Luis de la Fuente, Antonia Domingo-Salvany, José Pulido & Sara Santos. (2011) Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. International Journal of Drug Policy 22:1, pages 16-25.
Crossref
Crossref
M-J Milloy, Nadia Fairbairn, Kanna Hayashi, Paisan Suwannawong, Karyn Kaplan, Evan Wood & Thomas Kerr. (2010) Overdose experiences among injection drug users in Bangkok, Thailand. Harm Reduction Journal 7:1.
Crossref
Crossref
Lauren Enteen, Joanna Bauer, Rachel McLean, Eliza Wheeler, Emalie Huriaux, Alex H. Kral & Joshua D. Bamberger. (2010) Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco. Journal of Urban Health 87:6, pages 931-941.
Crossref
Crossref
Peter C. Britton, James D. WinesJr.Jr. & Kenneth R. Conner. (2010) Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug and Alcohol Dependence 107:1, pages 51-55.
Crossref
Crossref
Nabarun Dasgupta, Catherine Sanford, Susan Albert & Fred Wells BrasonIIII. (2009) Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention. American Journal of Lifestyle Medicine 4:1, pages 32-37.
Crossref
Crossref
Amy S.B. Bohnert, Melissa Tracy & Sandro Galea. (2009) Circumstances and Witness Characteristics Associated With Overdose Fatality. Annals of Emergency Medicine 54:4, pages 618-624.
Crossref
Crossref
Leo Beletsky, Scott C. Burris & Alex H. Kral. (2009) Closing Death's Door: Action Steps to Facilitate Emergency Opioid Drug Overdose Reversal in the United States. SSRN Electronic Journal.
Crossref
Crossref